Latest Healthcare News

Page 46 of 160
Vitasora Health Limited reported a significant 22% increase in daily clinical billing productivity for the December 2025 quarter, alongside a 17% rise in operating revenue. With new CMS reimbursement policies now in effect, the company anticipates a further 10–20% revenue uplift in 2026.
Ada Torres
Ada Torres
29 Jan 2026
Cyclopharm has launched a pioneering clinical study combining its Technegas imaging with AI analysis to explore a novel treatment for severe COPD, potentially expanding care options for millions.
Ada Torres
Ada Torres
29 Jan 2026
Doctor Care Anywhere reported steady consultation growth and a third consecutive quarter of positive cashflow in Q4 2025, while advancing digital health pilots and reaffirming ambitious medium-term revenue and profitability goals.
Ada Torres
Ada Torres
29 Jan 2026
ImpediMed reported a solid Q2 FY26 with $3.9 million in revenue and significant reimbursement gains for its lymphoedema technology, while launching new US Heart Health and Wellness initiatives.
Ada Torres
Ada Torres
29 Jan 2026
Epsilon Healthcare has posted a record $2.891 million in receipts for the December 2025 quarter, nearly doubling year-on-year revenue and marking a significant turnaround with its recent ASX reinstatement.
Ada Torres
Ada Torres
28 Jan 2026
Atomo Diagnostics reported a robust 121% quarter-on-quarter revenue increase to $1.5 million, driven by new orders for its FebriDx Pascal and HIV Self-Test products. The company also secured a global licensing deal for a novel liver function test and expanded manufacturing capacity to support growing demand.
Ada Torres
Ada Torres
28 Jan 2026
Patrys Limited has acquired Reliis, gaining a promising injectable formulation of quetiapine aimed at treating delirium with a rapid FDA approval pathway. This move positions Patrys at the forefront of addressing a significant unmet medical need in critical care.
Ada Torres
Ada Torres
28 Jan 2026
Patrys Limited has completed its acquisition of Reliis Pty Ltd, adding a promising injectable quetiapine program to its clinical pipeline and strengthening its board with two new directors.
Ada Torres
Ada Torres
28 Jan 2026
Imricor Medical Systems has achieved multiple world-first procedures using real-time MRI guidance for cardiac ablation, advancing clinical trials and regulatory progress amid a strategic commercial expansion.
Ada Torres
Ada Torres
28 Jan 2026
Emyria Limited has reported strong quarterly revenue growth driven by the expansion of its Empax clinic network across multiple Australian states, supported by a recent $8 million institutional placement to fund its national rollout and workforce expansion.
Ada Torres
Ada Torres
28 Jan 2026
Vection Technologies has reported a remarkable quarter with a 250% jump in customer cash receipts and a landmark $7.8 million Defence order, signalling a new phase of growth and operational strength.
Sophie Babbage
Sophie Babbage
28 Jan 2026
Epiminder Limited has successfully listed on the ASX, raising $125 million to commercialise its FDA-approved Minder device. The company has initiated the first US implant and secured five leading medical centres for its DETECT study.
Ada Torres
Ada Torres
28 Jan 2026